Danimer Scientific sees FY24 adjusted EBITDA ($35M) to ($30M)

Full-year capital expenditures are anticipated to remain in the previously disclosed range of $8 million to $10 million, which will support existing commitments related to the Bainbridge greenfield facility, maintenance expenditures and other capital projects.